The 1964 Alaska Good Friday Earthquake measured 9.2, making it the second most powerful earthquake ever recorded, behind only the 1960 Chile earthquake at 9.5.
Where this was said
At 2:09 · chapter starts 0:00
The episode opens with the standard iHeart intro before Josh and Chuck launch into a characteristically warm and witty cold open. Josh reveals a remarkable coincidence: the very first earthquake he ever felt occurred while he was reading about the 1964 Alaska earthquake, caused by a 6.8 tremor originating in Cuba and felt all the way in Central Florida. Chuck, who lived in Los Angeles for five years without ever feeling a quake, marvels at the irony. The exchange immediately illustrates one of the episode's central themes: that earthquakes reach far further than most people imagine. Josh jokes that 60 percent of listeners probably stopped listening when he put on an exaggerated voice, before reassuring the rest that they'd be sorry if they did — this is a story worth hearing.
The 1964 Alaska Good Friday Earthquake registered 9.2 on the Richter scale — the second most powerful ever recorded, behind only Chile's 9.5 in 1960. Despite its colossal force, only 131 people died, largely because Alaska was so sparsely populated.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.